HomeDealsAtrys

Atrys

Deal Type
Deal Type
Fundraising
Vital Sector
Sector
Healthcare
Completion Date
Completion Date
7th December 2020
Deal Value
Deal Value
€35m

Company Background

Atrys is a biomedical company dedicated to provide diagnostic services and excelence medical treatments. It aims is to facilitate patients with individualized therapy, as well as to develop new therapeutic modalities and diagnostic tools. Atrys is a public company listed in the Spanish BME Growth.

Deal Summary

Capital increase fully subscribed by institutional investors. NORGESTION acted as Registered Advisor of the company.

Atrys deal contacts

Key members of the Norgestion deal team crucial in the Atrys transaction

Jose Antonio Barrena

Norgestion